Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Effects of acetylsalicylic acid usage on inflammatory and oxidative stress markers in hemodialysis patients (2016)

  • Authors:
  • USP affiliated authors: COSTA, JOSÉ ABRÃO CARDEAL DA - FMRP
  • USP Schools: FMRP
  • DOI: 10.1007/s10753-015-0244-8
  • Subjects: ANTIOXIDANTES; BIOMARCADORES; ANALGÉSICOS; PERÓXIDO DE HIDROGÊNIO; INFLAMAÇÃO; VITAMINA A; VITAMINA E
  • Keywords: Hemodyalisis; Acetylsalicylic acid; Inflammation; Oxidative stress; Antioxidant vitamins
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Inflammation
    • ISSN: 0360-3997
    • Volume/Número/Paginação/Ano: v. 39, n. 1, p. 243-247, 2016
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s10753-015-0244-8 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s10753-015-0244-8 (Fonte: Unpaywall API)

    Título do periódico: Inflammation

    ISSN: 0360-3997,1573-2576



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Inflammation

    ISSN: 0360-3997

    Citescore - 2017: 2.92

    SJR - 2017: 1.023

    SNIP - 2017: 0.946


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2852831pcd 2852831 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      MANIGLIA, Fabíola Pansani; COSTA, José Abrão Cardeal da. Effects of acetylsalicylic acid usage on inflammatory and oxidative stress markers in hemodialysis patients. Inflammation, New York, v. 39, n. 1, p. 243-247, 2016. Disponível em: < http://dx.doi.org/10.1007/s10753-015-0244-8 > DOI: 10.1007/s10753-015-0244-8.
    • APA

      Maniglia, F. P., & Costa, J. A. C. da. (2016). Effects of acetylsalicylic acid usage on inflammatory and oxidative stress markers in hemodialysis patients. Inflammation, 39( 1), 243-247. doi:10.1007/s10753-015-0244-8
    • NLM

      Maniglia FP, Costa JAC da. Effects of acetylsalicylic acid usage on inflammatory and oxidative stress markers in hemodialysis patients [Internet]. Inflammation. 2016 ; 39( 1): 243-247.Available from: http://dx.doi.org/10.1007/s10753-015-0244-8
    • Vancouver

      Maniglia FP, Costa JAC da. Effects of acetylsalicylic acid usage on inflammatory and oxidative stress markers in hemodialysis patients [Internet]. Inflammation. 2016 ; 39( 1): 243-247.Available from: http://dx.doi.org/10.1007/s10753-015-0244-8

    Referências citadas na obra
    Jofré, R., P. Rodriguez-Benitez, J.M. López-Gómez, and R. Pérez-Garcia. 2006. Inflammatory syndrome in patients on hemodialysis. Journal of the American Society of Nephrology 17: 274–280.
    Ajala, M.O., P.S. Ogunro, and A. Odun. 2011. Effect of hemodialysis on total antioxidant status of chronic renal failure patients in government hospitals in Lagos Nigeria. Nigerian Journal of Clinical Practice 14: 154–158.
    Vecchi, A.F., F. Bamonti, C. Novembrino, et al. 2009. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients. Nephrology, Dialysis, Transplantation 24: 2524–2529.
    Abahusain, M.A., and N.N. Al-Nahedh. 2002. The biochemical status of vitamin A and alpha-tocopherol during different stages of renal disease and its relationship to diabetes. Saudi Journal of Kidney Diseases and Transplantation 13: 18–23.
    Santangelo, F., V. Witko-Sarsat, T. Drüeke, and B. Descamps-Latscha. 2004. Restoring glutathione as a therapeutic strategy in chronic kidney disease. Nephrology, Dialysis, Transplantation 19: 1951–1955.
    Montazerifar, F., M. Hashemi, M. Karajibani, and M. Dikshit. 2010. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans. Journal of Medicinal Food 13: 1490–1493.
    Menon, V., T. Greene, X. Wang, et al. 2005. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney International 68: 766–772.
    Bergstrom, J., and B. Lindholm. 1998. Malnutrition, cardiac disease, and mortality: an integrated point of view. American Journal of Kidney Diseases 32: 834–841.
    Zyga, S., C.A. Hutchison, S. Stringer, et al. 2014. Inflammation and endothelial dysfunction in the initiation and propagation of cardiovascular disease in patients with chronic kidney disease. British Journal of Medical Research 4: 2568–2580.
    Sundaram, S.P.M., S. Nagarajan, and A.J.M. Devi. 2014. Chronic kidney disease—effect of oxidative stress. Chinese Journal of Biology 2014: 1–6.
    Wali, R.K. 2010. Aspirin and the prevention of cardiovascular disease in chronic kidney disease. Journal of the American College of Cardiology 56: 966–968.
    Sociedade Brasileira de Cardiologia. 2013. Diretrizes brasileiras de antiagregantes plaquetários e anticoagulantes em cardiologia. Arquivos Brasileiros de Cardiologia 101: 1–95.
    Antiplatelet Trialists’ Collaboration. 1994. Bulário Eletrônico: Aspirina [internet]. Brasília: Ministério da Saúde. Agência Nacional de Vigilância Sanitária (ANVISA) 2009. British Medical Journal 308: 81-106. Available at: http://www4.anvisa.gov.br/base/visadoc/BM/BM[25345-1-0].PDF [Date accessed: 7 January 2013]
    Kalantar-Zadeh, K., J.D. Kopple, G. Block, and M.H. Humphreys. 2001. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. American Journal of Kidney Diseases 38: 1251–1263.
    Roberts, W.L., R. Sedrick, L. Moulton, A. Spencer, and N. Rifai. 2000. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clinical Chemistry 46: 461–468.
    Södergren, E. et al. 1998. Re-evaluation of the ferrous oxidation in xylenol orange assay for the measurement of plasma lipid hydroperoxides. Journal of Biochemical and Biophysical Methods 37: 137–146.
    Nourooz-Zadeh, J., J. Tajaddini-Sarmadi, and S.P. Wolff. 1994. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Analytical Biochemistry 220: 403–9.
    Galli, F., M. Piroddi, C. Annetti, C. Aisa, E. Floridi, and A. Floridi. 2005. Oxidative stress and reactive oxygen species. Contributions to Nephrology 149: 240–60.
    Gerard-Monnier, D., I. Erdelmeier, K. Régnard, N. Moze-Henry, J.C. Yadan, and J. Chaudière. 1998. Reactions of 1-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Analytical applications to a colorimetric assay of lipid peroxidation. Chemical Research in Toxicology 11: 1176–83.
    Ellman, G.L. 1959. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 82: 70–7.
    Hu, M.L. 1994. Measurement of protein thiol groups and glutathione in plasma. Methods in Enzymology 233: 380–5.
    Arnaud, J., I. Fortis, S. Blachier, D. Kia, and A. Favier. 1991. Simultaneous determination of retinol, alpha-tocopherol and beta-carotene in serum by isocratic high-performance liquid chromatography. Journal of Chromatography 572: 103–16.
    Huang, Y., Y. Zhong, X. Ding, et al. 2011. Aspirin can reduce serum C reactive protein level in maintenance hemodialysis patients. Chinical Journal of Nephrology 27: 271–275.
    Waterman, M., B. Fuhrman, S. Keidar, and T. Hayek. 2009. Aspirin promotes low density lipoprotein susceptibility to oxidative modification in healthy volunteers. The Israel Medical Association Journal 11: 730–734.
    Selvakumar, C., U. Maheshwari, X. Suganthi, and X. Archana. 2012. Oxidant-antioxidant disturbance in men classified as obese according to the preliminary WHO guidelines for Asians. Journal of Stress Physiology & Biochemistry 8: 172–181.
    Steer, K.A., T.M. Wallace, C.H. Bolton, and M. Hartog. 1997. Aspirin protects low density lipoprotein from oxidative modification. Heart 77: 333–337.
    Kirkova, M., E. Ivancheva, and E. Russanov. 1994. In vitro effects of aspirin on malondialdehyde formation and on activity of antioxidant and some metal-containing enzymes. Comparative Biochemistry and Physiology. Pharmacology, Toxicology and Endocrinology 108: 145–52.
    Young, D.S. 1987. Implementation of SI units for clinical laboratory data. Annals of Internal Medicine 106: 114–129.
    Espe, K.M., J. Raila, A. Henze, et al. 2011. Impact of vitamin A on clinical outcomes in haemodialysis patients. Nephrology, Dialysis, Transplantation 26: 4054–4061.
    Podhaisky, H.P., A. Abate, T. Polte, S. Oberle, and H. Schröder. 1997. Aspirin protects endothelial cells from oxidative stress: possible synergism with vitamin E. FEBS Letters 417: 349–351.
    Espe, K.M., J. Raila, A. Henze, et al. 2013. Low plasma a-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients. Clinical Journal of the American Society of Nephrology 8: 1–7.